Who takes the lead when science has no commercial business model? Read more about Who takes the lead when science has no commercial business model?
Oncode Institute and Ligase BioPartners scale proven oncology investment model with launch of Oncology Bridge Fund II Read more about Oncode Institute and Ligase BioPartners scale proven oncology investment model with launch of Oncology Bridge Fund II
Leadership transition at Oncode Accelerator strengthens alignment with Oncode Institute Read more about Leadership transition at Oncode Accelerator strengthens alignment with Oncode Institute
Shedding light on what cancer hides: the story behind team ILLUMINE Read more about Shedding light on what cancer hides: the story behind team ILLUMINE
Tracing the fingerprints of DNA damage: the story behind team CAUSE Read more about Tracing the fingerprints of DNA damage: the story behind team CAUSE
Four Oncode Institute Investigators awarded prestigious Cancer Grand Challenges grants Read more about Four Oncode Institute Investigators awarded prestigious Cancer Grand Challenges grants
Oncode researcher awarded prestigious NWO Vici grant for breakthrough prostate cancer research Read more about Oncode researcher awarded prestigious NWO Vici grant for breakthrough prostate cancer research
Giving a human face to the OutMARCH project Read more about Giving a human face to the OutMARCH project
Oncode spin-off Omivera secures UNIIQ seed investment for CellEKT platform Read more about Oncode spin-off Omivera secures UNIIQ seed investment for CellEKT platform
Alpe d’HuZes/KWF Fund gives additional €4.5 million boost to Oncode Institute to accelerate innovative cancer research Read more about Alpe d’HuZes/KWF Fund gives additional €4.5 million boost to Oncode Institute to accelerate innovative cancer research